G Medical Innovations Holdings GMVDF · USD

Its shares trade under the ticker GMVDF. It has been listed since 26 October 2017. In the fiscal year to 31 December 2019, it reported revenue of $5.5m and a net loss of $15.0m. At that date it held total assets of $8.8m and shareholders' equity of −$13.4m.

G Medical Innovations Holdings Ltd. operates as a mobile health and digital health company, which engages in the development and marketing clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for remote monitoring and telemedicine projects. The firm is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. The company develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. The company also develops wireless vital signs monitoring systems.

Figures and description from our data supplier, not checked against the company's own report.

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.